Protalix BioTherapeutics PLX Balance Sheet (2010-2026)

NYSE PLX
$2.71 +0.04 (+1.69%)
As of: Sep 10, 2026 · 2:44 PM EDT
Reported Financials

Protalix BioTherapeutics Quarterly Balance Sheet

Periods 63 quarters
Latest Jun 2026

Protalix BioTherapeutics reported total assets of $110.34M and total liabilities of $38.93M for the quarter ended Jun 2026, up 40.6% year over year. This balance sheet covers 63 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
10.64M38.98M16.89M12.49M10.72M17.11M33.04M48.18M20.41M23.63M27.21M23.40M27.41M19.76M19.46M17.89M13.65M14.68M41.00M27.42M
Short-term InvestmentsInvestments (Current)
38.02M16.03M16.08M10.09M5.07M20.57M20.93M21.28M21.63M15.07M15.29M15.50M15.72M15.59M10.08M13.24M
Cash & Current Investments
48.66M38.98M32.92M28.57M20.81M22.18M33.04M48.18M40.98M44.56M48.49M45.03M27.41M34.83M34.74M33.40M29.37M30.27M51.08M40.66M
Receivables - NetNet Receivables
5.56M3.44M5.91M2.02M8.65M4.59M1.30M4.05M8.94M5.27M3.76M10.13M2.19M2.91M4.67M9.44M14.43M8.84M2.94M16.50M
Receivables - OtherOther Receivables
Receivables
5.56M3.44M5.91M2.02M8.65M4.59M1.30M4.05M8.94M5.27M3.76M10.13M2.19M2.91M4.67M9.44M14.43M8.84M2.94M16.50M
Raw Materials
3.17M3.17M3.07M3.30M3.66M3.51M4.31M4.35M4.20M4.18M4.02M4.30M4.24M4.55M4.48M4.36M4.98M5.98M6.01M6.08M
Work In Process
3.51M3.26M3.37M3.30M2.62M2.68M1.53M3.32M9.12M9.05M9.17M10.87M12.25M11.24M8.00M8.14M5.36M9.38M9.08M8.25M
Finished Goods
8.05M11.53M10.16M9.91M8.28M10.62M14.46M11.96M8.27M5.81M9.15M5.54M0.71M5.45M7.02M8.63M10.92M10.37M15.38M17.95M
Inventory
14.73M17.95M16.59M16.51M14.56M16.80M20.30M19.64M21.58M19.05M22.35M20.72M17.20M21.24M19.51M21.13M21.25M25.73M30.47M32.29M
Prepaid Assets
2.27M1.28M1.12M2.60M1.74M1.31M0.76M1.71M1.12M1.05M0.81M1.49M1.05M1.10M1.59M1.51M1.45M1.13M1.15M2.05M
Current Assets
71.22M61.67M56.54M49.70M45.76M44.88M55.40M73.58M72.62M69.93M75.40M77.37M47.85M60.08M60.51M65.48M66.50M66.67M86.36M92.22M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
5.07M4.96M4.89M4.77M4.68M4.55M4.70M4.64M4.68M4.97M4.78M4.61M4.65M4.59M4.72M4.75M4.72M4.88M5.15M5.47M
Long-Term Investments
1.95M2.08M2.05M1.40M1.42M1.27M1.25M1.27M1.26M0.53M0.53M0.54M0.56M0.46M0.46M0.52M0.55M0.58M0.59M
Long-Term Deferred Tax
3.13M3.09M3.09M3.23M3.30M2.86M2.86M2.97M2.74M2.68M2.52M2.44M2.37M
Other Non-Current Assets
Non-Current Assets
12.26M12.00M11.85M10.94M10.95M10.91M11.16M14.84M14.95M14.50M14.42M14.17M13.71M13.34M13.38M13.00M15.76M15.67M15.98M18.12M
Assets
83.48M73.67M68.39M60.64M56.71M55.79M66.56M88.42M87.57M84.43M89.83M91.54M61.56M73.42M73.89M78.49M82.26M82.35M102.34M110.34M
Liabilities
Current Liabilities
Accounts Payables
14.69M16.43M14.41M12.66M12.87M12.27M13.47M18.55M18.74M4.32M18.77M19.34M19.58M4.53M4.12M6.69M5.38M5.26M4.29M6.51M
Notes Payables
Payables
14.69M16.43M14.41M12.66M12.87M12.27M13.47M18.55M18.74M4.32M18.77M19.34M19.58M4.53M4.12M6.69M5.38M5.26M4.29M6.51M
Accumulated Expenses
9.01M9.57M9.35M7.31M8.13M9.79M9.69M9.96M
Other Accumulated Expenses
0.64M1.08M0.30M0.76M0.56M0.80M0.97M1.56M
Short term Debt
3.24M20.19M20.25M20.42M20.42M
Current Leases
1.24M1.21M1.24M1.08M1.00M1.12M1.15M1.26M1.31M1.41M1.45M1.45M1.51M1.50M1.43M1.47M1.40M1.38M1.43M1.67M
Current Taxes
2.88M3.48M3.48M3.74M2.38M2.95M3.20M4.21M
Current Deferred Revenue
15.16M8.55M11.80M10.22M14.79M13.18M11.79M11.04M12.70M2.00M
Total Current Liabilities
42.76M33.18M35.33M30.96M34.30M32.43M31.52M23.11M43.36M45.53M54.83M57.97M24.22M25.62M24.32M24.09M21.95M26.52M27.39M31.39M
Non-Current Liabilities
Non-Current Debt
Convertible Debt
27.82M27.89M27.96M28.03M28.11M28.19M28.27M20.13M20.42M
Non-Current Deffered Revenue
5.89M11.79M5.89M5.89M
Pension
2.35M2.47M2.50M1.75M1.78M1.64M1.62M1.60M1.46M0.71M0.71M0.70M0.73M0.56M0.55M0.61M0.63M0.66M0.67M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
28.50M14.40M11.90M14.60M
Operating Leases
4.44M4.38M4.19M3.89M4.03M4.17M4.15M4.58M4.50M4.62M4.50M4.28M4.18M4.03M3.81M3.88M6.78M6.94M7.05M7.54M
Other Non-Current Liabilities
Total Non-Current Liabilities
40.51M46.52M40.55M39.57M33.92M34.00M34.04M26.31M5.96M5.33M5.21M4.99M4.91M4.58M4.36M4.49M7.41M7.60M7.72M7.54M
Total Liabilities
83.27M79.70M75.88M70.53M68.22M66.43M65.55M49.42M49.32M50.87M60.04M62.96M29.13M30.21M28.68M28.58M29.36M34.12M35.11M38.93M
Shareholder's Equity
Total Debt
3.24M20.19M20.25M20.42M20.42M
Common Equity
0.21M-6.04M-7.49M120.00M-11.51M-10.64M1.01M39.00M38.25M33.57M29.79M28.58M32.44M43.21M45.21M49.90M52.91M48.23M67.23M71.40M
Liabilities and Shareholders Equity
83.48M73.67M68.39M60.64M56.71M55.79M66.56M88.42M87.57M84.43M89.83M91.54M61.56M73.42M73.89M78.49M82.26M82.35M102.34M110.34M
Retained Earnings
-374.93M-389.86M-381.55M-378.39M-385.00M